REG-Bodycote Plc: Response to statement by Apollo

BodycoteAnnouncement

Today 07:10

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE
OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

FOR IMMEDIATE RELEASE

 

5 June 2026

 

Bodycote plc

 

Response to statement by Apollo

 

The Board of Bodycote plc ("Bodycote") notes the statement by Apollo
Management X, L.P. (together with Apollo Global Management, Inc. and its
subsidiaries ("Apollo")), on behalf of certain of its managed investment
funds, that it does not intend to make a firm offer for Bodycote and that it
is consequently bound by the restrictions under Rule 2.8 of the City Code on
Takeovers and Mergers (the "Code").

 

The Board of Bodycote has strong confidence in Bodycote's potential and its
strategy to create a high-performing, resilient business with attractive
growth prospects. Bodycote continues to execute well on the group's Optimise,
Perform and Grow initiatives, with a positive start to 2026 trading as set out
in the AGM trading update of 27 May 2026.

 

As a result of the announcement by Apollo, Bodycote is no longer in an offer
period for the purposes of the Code.

 

 

Enquiries:

 

 Bodycote plc     Jim Fairbairn, Chief Executive Officer  Ben Fidler, Chief Financial Officer  Peter Lapthorn, Head of FP&A and Investor Relations  +44 (0) 16 2550 5300  
                                                                                                                                                                          
 FTI Consulting        (PR Adviser)   Richard Mountain  Edward Knight                                                                               +44 (0) 20 3727 1340  

Barclays Bank PLC, Goldman Sachs International and Jefferies are acting as
financial advisers to Bodycote.

 

Disclaimers

 

Barclays Bank PLC, acting through its Investment Bank ("Barclays"), which is
authorised by the Prudential Regulation Authority and regulated in the United
Kingdom by the Financial Conduct Authority and the Prudential Regulation
Authority, is acting exclusively for Bodycote and no one else in connection
with the matters set out in this announcement and will not be responsible to
anyone other than Bodycote for providing the protections afforded to clients
of Barclays nor for providing advice in relation to any matter referred to in
this announcement.

 

In accordance with the Code, normal United Kingdom market practice and Rule
14e-5(b) of the Securities Exchange Act 1934 of the United States, Barclays
and its affiliates will continue to act as exempt principal trader in Bodycote
securities on the London Stock Exchange. These purchases and activities by
exempt principal traders which are required to be made public in the United
Kingdom pursuant to the Code will be reported to a Regulatory Information
Service and will be available on the London Stock Exchange website at
www.londonstockexchange.com. This information will also be publicly disclosed
in the United States to the extent that such information is made public in the
United Kingdom.

 

Goldman Sachs International, which is authorised by the Prudential Regulation
Authority and regulated by the Financial Conduct Authority and the Prudential
Regulation Authority in the United Kingdom, is acting exclusively for Bodycote
and no one else in connection with the matters referred to in this
announcement and will not be responsible to anyone other than Bodycote for
providing the protections afforded to clients of Goldman Sachs International,
or for providing advice in connection with the matters referred to in this
announcement.

 

Jefferies International Limited ("Jefferies"), which is authorised and
regulated by the FCA in the UK, is acting exclusively as financial adviser and
corporate broker to Bodycote and no one else in connection with the matters
described in this announcement and will not regard any other person as its
client in relation to the matters in this announcement and will not be
responsible to anyone other than Bodycote for providing the protections
afforded to clients of Jefferies nor for providing advice in relation to any
matter referred to in this announcement. Neither Jefferies nor any of its
affiliates (nor their respective directors, officers, employees or agents)
owes or accepts any duty, liability or responsibility whatsoever (whether
direct or indirect, whether in contract, in tort, under statute or otherwise)
to any person who is not a client of Jefferies in connection with this
announcement, any statement contained herein or otherwise.

 

Additional Information

 

This announcement is not intended to, and does not, constitute or form part of
any offer, invitation or the solicitation of an offer to purchase, otherwise
acquire, subscribe for, sell or otherwise dispose of, any securities, or the
solicitation of any vote or approval in any jurisdiction, pursuant to this
announcement or otherwise.

 

This announcement has been prepared in accordance with English law and
information disclosed may not be the same as that which would have been
disclosed in accordance with the laws of jurisdictions outside England. The
release, publication or distribution of this announcement in whole or in part,
directly or indirectly, in, into or from certain jurisdictions other than the
United Kingdom and the availability of any offer to shareholders of Bodycote
should one be made who are not resident in the United Kingdom may be affected
by the laws of relevant jurisdictions. Therefore, any persons who are subject
to the laws of any jurisdiction other than the United Kingdom or shareholders
of Bodycote who are not resident in the United Kingdom will need to inform
themselves about, and observe, any applicable requirements.

 

 



Copyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved